Search - tctmd.com

Displaying 121 - 140 of 1726

Sort: Relevancy | Date

Presentation TCT 2024

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

Presenter: Jeremy Levett

October 28, 2024

Presentation TCT 2024

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Kiril Karamfiloff

October 28, 2024

Presentation TCT 2024

Practical Considerations: DCB vs Repeat Stenting With DES

Presenter: Kyung Woo Park

October 28, 2024

Presentation TCT 2024

How Essential is Intravascular Imaging to the DCB Toolkit?

Presenter: Fernando Alfonso

October 28, 2024

Presentation TCT 2024

Comparison of Noncompliant Balloon With Drug-Coating Balloon Angioplasties for Side Branch After Provisional Stenting for Patients With True Coronary BIFurcation Lesions: The Prospective, Multicenter, Randomized DCB-BIF Trial

Presenter: Shao-Liang Chen

October 28, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

Presenter: David Erlinge

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Presentation TCT 2024

TCT 358: Case Series of Coronary Artery Pseudoaneurysm With Extra Luminal Migration of Drug Eluting Stent Following Percutaneous Coronary Intervention

Presenter: Arun Mohanty

October 27, 2024

Presentation TCT 2024

TCT 407: Clinical Characteristics and Outcomes of Impella Supported High-Risk Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion: Insights From the cVAD PROTECT III Registry

Presenter: Batla Falah

October 27, 2024

Presentation TCT 2024

TCT 406: Outcomes in Patients With Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention With Drug-Coated Balloons

Presenter: HUAN YEAN KANG

October 27, 2024

Presentation TCT 2024

TCT 405: Drug Coated Balloons in EuroCTO Registry

Presenter: Niccolò Ciardetti

October 27, 2024

Presentation TCT 2024

TCT 404: Trends of Drug Coated Balloon Use in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry

Presenter: Deniz Mutlu

October 27, 2024

Presentation TCT 2024

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

Presenter: Emi Kearon

October 27, 2024

Presentation TCT 2024

Magnesium-Based Resorbable Scaffold vs Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: Final 5-Year Results of the MAGSTEMI Randomized Controlled Trial

Presenter: Manel Sabate

October 27, 2024

Presentation TCT 2024

Impact of Small or Non-Small Vessel Disease to Drug-Coated Balloon Angioplasty for the Treatment of De Novo Coronary Artery Lesions: Insights From the REC-CAGEFREE I Trial

Presenter: Patrick Serruys

October 27, 2024

Presentation TCT 2024

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Presenter: Alexandra Lansky

October 27, 2024

Presentation TCT 2024

TCT 853: Drug-Coated Balloons in Calcified Lesions: Managing the Rock Without Metal

Presenter: Gianluca Mincione

October 27, 2024

Presentation TCT 2024

TCT 364: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions: 5 Clinical Year Outcomes

Presenter: Matthias Lutz

October 27, 2024

Presentation TCT 2024

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

Presenter: Jiasheng Yin

October 27, 2024

Presentation TCT 2024

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

Presenter: Kirstine Hansen

October 27, 2024

Advertisement

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Practical Considerations: DCB vs Repeat Stenting With DES

How Essential is Intravascular Imaging to the DCB Toolkit?

Comparison of Noncompliant Balloon With Drug-Coating Balloon Angioplasties for Side Branch After Provisional Stenting for Patients With True Coronary BIFurcation Lesions: The Prospective, Multicenter, Randomized DCB-BIF Trial

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

TCT 358: Case Series of Coronary Artery Pseudoaneurysm With Extra Luminal Migration of Drug Eluting Stent Following Percutaneous Coronary Intervention

TCT 407: Clinical Characteristics and Outcomes of Impella Supported High-Risk Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion: Insights From the cVAD PROTECT III Registry

TCT 406: Outcomes in Patients With Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention With Drug-Coated Balloons

TCT 405: Drug Coated Balloons in EuroCTO Registry

TCT 404: Trends of Drug Coated Balloon Use in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

Magnesium-Based Resorbable Scaffold vs Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: Final 5-Year Results of the MAGSTEMI Randomized Controlled Trial

Impact of Small or Non-Small Vessel Disease to Drug-Coated Balloon Angioplasty for the Treatment of De Novo Coronary Artery Lesions: Insights From the REC-CAGEFREE I Trial

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

TCT 853: Drug-Coated Balloons in Calcified Lesions: Managing the Rock Without Metal

TCT 364: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions: 5 Clinical Year Outcomes

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content